Sr Director, Quality Large Molecule
Thermo Fisher ScientificSalary not specified
- Full Time
- Expert & Leadership (9+ years)
$60,000 – $90,000Compensation
Mid-level (3 to 4 years), Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceutical, Quality AssuranceIndustries
Requirements
Candidates should possess a Bachelor’s degree in a relevant scientific field, such as Biology, Chemistry, or Pharmaceutical Sciences, and have at least five years of experience in quality assurance or training within a pharmaceutical or biotechnology environment. Strong understanding of quality systems, regulatory requirements (including FDA and GMP guidelines), and training methodologies is essential. Experience with electronic Quality Management Systems (eQMS) is highly desirable.
Responsibilities
The Senior Quality Training Specialist will assist with the implementation of the RayzeBio Training Management program, setup new users in the eQMS, maintain training matrices, assign training courses, organize instructor-led training courses, update eQMS users, inactivate users upon departure, and ensure documented training evidence. They will also participate in establishing training best practices, working with Human Resources to ensure personnel maintain updated job roles and responsibilities, and serve as a subject matter expert in management related to quality systems.
Skills
GMP
FDA
Quality Systems
Training Methodologies
eQMS
Regulatory Requirements
Documentation
Auditing
Bristol-Myers Squibb
Develops and delivers biopharmaceutical medicines
About Bristol-Myers Squibb
Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.
New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees